Ophthalmological and electrophysiological features of parkinson's disease

Klinika Oczna

Volumn 112, Issue 7-9, 2010, Pages 247-252

  Barbara, Nowacka ^a,b   Wojciech, Lubiński ^a   Danuta, Karczewicz ^a  

^a POMERANIAN MEDICAL UNIVERSITY   (Poland)

^b Powsta ców Wlkp   (Poland)

Author keywords

Associated ocular diseases and symptoms; EOG; ERG; MfERG; Parkinson's disease; PERG; VEP

Indexed keywords

DRY EYE; ELECTROPHYSIOLOGY; GLAUCOMA; HUMAN; PARKINSON DISEASE; PATHOPHYSIOLOGY; RETINA; REVIEW; VISION; VISUAL ACUITY; VISUAL DISORDER; VISUAL SYSTEM; VISUAL SYSTEM EXAMINATION;

DIAGNOSTIC TECHNIQUES, OPHTHALMOLOGICAL; DRY EYE SYNDROMES; ELECTROPHYSIOLOGICAL PROCESSES; GLAUCOMA; HUMANS; PARKINSON DISEASE; RETINA; VISION DISORDERS; VISION, OCULAR; VISUAL ACUITY; VISUAL PATHWAYS; VISUAL PERCEPTION;

EID: 79952115798     PISSN: 00232157     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Friedman A: Choroba Parkinsona - mechanizmy, rozpoznanie, leczenieWyd. 1. Lublin, Czelaj 2005, 5763,139-145.
2. Koller W, O'Hara R, Weiner W, Lang A, Nutt J, Agid Y, Bonnet AM, Jankovic J: Relationship of aging to Parkinson's disease. Adv Neurol 1987;45:317-21.
3. Rajput AH: Levodopa prolongs life expectancy and is non-toxic to substantia nigra. Parkinsonism Relat Disord 2001 Oct, 8(2), 95-100.
4. Dawson TM: Failures and successes of clinical trials for Parkinson disease treatments. Retina 2005 Dec, 25(8 Suppl), S75-S77.
5. Hughes AJ, Daniel SE, Ben-Shlomo Y, Lees AJ: The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service. Brain 2002 Apr, 125(Pt 4), 861-870. (Pubitemid 34279780)
6. Djamgoz MB, Hankins MW, Hirano J, Archer SN: Neurobiology of retinal dopamine in relation to degenerative states of the tissue. Vision Res 1997 Dec, 37(24), 3509-3529. (Pubitemid 27491631)
7. Archibald NK, Clarke MP, Mosimann UP, Burn DJ: The retina in Parkinson's disease. Brain 2009 May, 132(Pt 5), 1128-1145.
8. Wink B, Harris J: A model of the Parkinsonian visual system: support for the dark adaptation hypothesis. Vision Res 2000, 40(14), 1937-1946. (Pubitemid 30317281)
9. Price MJ, Feldman RG, Adelberg D, Kayne H: Abnormalities in color vision and contrast sensitivity in Parkinson's disease. Neurology 1992 Apr, 42(4), 887-890.
10. Pieri V, Diederich NJ, Raman R, Goetz CG: Decreased color discrimination and contrast sensitivity in Parkinson's disease. J Neurol Sci 2000 Jan 1,172(1), 7-11. (Pubitemid 30006974)
11. Davidsdottir S, Cronin-Golomb A, Lee A: Visual and spatial symptoms in Parkinson's disease. Vision Res 2005 May, 45(10), 1285-1296. (Pubitemid 40331887)
12. Grant GB, Werblin F: Dopaminergic modulation of a sustained, voltage-gated calcium current in vertebrae rods of the trigger salamander. Invest Ophthalmol Vis Sci 1990,31 (Suppl.), 176.
13. Dubocovich ML: Role of Melatonin in Retina. Progress in Retinal Research 1988,129-151.
14. Nguyen-Legros J, Versaux-Botteri C, Vernier P: Dopamine receptor localization in the mammalian retina. Mol Neurobiol 1999 Jun, 19(3), 181-204. (Pubitemid 29418891)
15. de Maindreville AD, Fénelon G, Mahieux F: Hallucinations in Parkinson's disease: a follow-up study. Mov Disord 2005 Feb, 20(2), 212-217. (Pubitemid 40361126)
16. Barnes J, David AS: Visual hallucinations in Parkinson's disease: a review and phenomenological survey. J Neurol Neurosurg Psychiatry 2001 Jun, 70(6), 727-733. (Pubitemid 32554201)
17. Biousse V, Skibell BC, Watts RL, Loupe DN, Drews-Botsch C, Newman NJ: Ophthalmologic features of Parkinson's disease. Neurology 2004 Jan 27, 62(2), 177-180. (Pubitemid 38167121)
18. Onofrj M, Bonanni L, Albani G, Mauro A, Bulla D, Thomas A: Visual hallucinations in Parkinson's disease: clues to separate origins. J Neurol Sci 2006 Oct 25, 248(1-2), 143-150. (Pubitemid 44754867)
19. Matsui H, Udaka F, Tamura A, Oda M, Kubori T, Nishinaka K, Kameyama M: Impaired visual acuity as a risk factor for visual hallucinations in Parkinson's disease. J Geriatr Psychiatry Neurol 2006 Mar, 19(1), 36-40. (Pubitemid 43797605)
20. Diederich NJ, Goetz CG, Raman R, Pappert EJ, Leurgans S, Piery V: Poor visual discrimination and visual hallucinations in Parkinson's disease. Clin Neuropharmacol 1998 Sep-Oct, 21(5), 289-295. (Pubitemid 28491429)
21. Matsui H, Udaka F, Tamura A, Oda M, Kubori T, Nishinaka K, Kameyama M: The relation between visual hallucinations and visual evoked potential in Parkinson disease. Clin Neuropharmacol 2005 Mar-Apr, 28(2), 79-82. (Pubitemid 40471881)
22. Tamer C, Melek IM, Duman T, Oksüz H: Tear film tests in Parkinson's disease patients. Ophthalmology 2005 Oct, 112(10), 1795.
23. Kandel ER, Schwartz, Jessell TM: Principles of Neural Science 3rd ed. New York: Elsevier 1991, 647-659.
24. Bayer AU, Keller ON, Ferrari F, Maag KP: Association of glaucoma with neurodegenerative diseases with apoptotic cell death: Alzheimer's disease and Parkinson's disease. Am J Ophthalmol 2002 Jan, 133(1), 135-137. (Pubitemid 34076513)
25. Yenice O, Onal S, Midi I, Ozcan E, Temel A, l-Gunal D: Visual field analysis in patients with Parkinson's disease. Parkinsonism Relat Disord 2008,14(3), 193-198. (Pubitemid 351458421)
26. Altinaş O, lseri PK, Tokay T, Yüksel N: Relationship between cognitive impairment and retinal morphological and visual functional abnormalities in Alzheimer disease. J Neuroophthalmol 2006 Mar, 26(1), 18-24. (Pubitemid 44502755)
27. Inzelberg R, Ramirez JA, Nisipeanu P, Ophir A: Retinal nerve fiber layer thinning in Parkinson disease. Vision Res 2004 Nov, 44(24), 2793-2797. (Pubitemid 39165558)
28. Hamilton SR: Neuro-ophthalmology of movement disorders. Curr Opin Ophthalmol 2000 Dec, 11(6), 403-407.
29. Armstrong IT, Chan F, Riopelle RJ, Munoz DP: Control of saccades in Parkinson's disease. Brain Cogn 2002 Jul, 49(2), 198-201.
30. Chan F, Armstrong IT, Pari G, Riopelle RJ, Munoz DP: Deficits in saccadic eye-movement control in Parkinson's disease. Neuropsychology 2005, 43(5), 784-796. (Pubitemid 40254347)
31. Mosimann UP, Muri RM, Burn DJ, Felblinger J, O'Brien JT, McKeith IG: Saccadic eye movement changes in Parkinson's disease dementia and dementia with Lewy bodies. Brain 2005 Jun, 128(Pt 6), 1267-1276. (Pubitemid 40826181)
32. Price MJ, Feldman RG, Adelberg D, Kayne H: Abnormalities in color vision and contrast sensitivity in Parkinson's disease. Neurology 1992 Apr, 42(4), 887-890.
33. Sartucci F, Orlandi G, Lucetti C, Bonuccelli U, Murri L, Orsini C, Porciatti V: Changes in pattern electroretinograms to equiluminant red-green and blue-yellow gratings in patients with early Parkinson's disease. J Clin Neurophysiol 2003 Sep-Oct, 20(5), 375-381. (Pubitemid 38031212)
34. Sartucci F, Orlandi G, Bonuccelli U, Borghetti D, Murri L, Orsini C, Domenici L, Porciatti V: Chromatic pattern-reversal electroretinograms (ChPERGs) are spared in multiple system atrophy compared with Parkinson's disease. Neurol Sci 2006 Feb, 26(6), 395-401.
35. Pieri V, Diederich NJ, Raman R, Goetz CG: Decreased color discrimination and contrast sensitivity in Parkinson's disease. J Neurol Sci 2000 Jan 1,172(1), 7-11. (Pubitemid 30006974)
36. Uc EY, Rizzo M, Anderson SW, Qian S, Rodnitzky RL, Dawson JD: Visual dysfunction in Parkinson disease without dementia. Neurology 2005 Dec 27, 65(12), 1907-1913. (Pubitemid 43970109)
37. Hokoc JN, Mariani AP: Tyrosine hydroxylase immunoreactivity in the rhesus monkey retina reveals synapses from bipolar cells to dopaminergic amacrine cells. J Neurosci 1987 Sep, 7(9), 2785-2793.
38. Peppe A, Stanzione P, Pierantozzi M, Semprini R, Bassi A, Santilli AM, Formisano R, Piccolino M, Bernardi G: Does pattern electroretinogram spatial tuning alteration in Parkinson's disease depend on motor disturbances or retinal dopaminergic loss? Electroencephalogr Clin Neurophysiol 1998 Apr, 106(4), 374-382.
39. Bodis-Wollner I, Antal A: On the functional significance of primate retinal dopamine receptors. J Neural Transm Suppl 1995, 45, 67-74.
40. Ikeda H, Head GM, Ellis CJ: Electrophysiological signs of retinal dopamine deficiency in recently diagnosed Parkinson's disease and a follow up study. Vision Res 1994 Oct, 34(19), 2629-2638. (Pubitemid 24256856)
41. Linsenmeier RA, Steinberg RH: A light-evoked interaction of apical and basal membranes of retinal pigment epithelium; c-wave and light peak. Journal of Neuropsychological 1983, 50, 136-147. (Pubitemid 13034127)
42. Nightingale S, Mitchell KW, Howe JW: Visual evoked cortical potentials and pattern electroretinograms in Parkinson's disease and control subjects. J Neurol Neurosurg Psychiatry 1986 Nov, 49(11), 1280-1287. (Pubitemid 17174030)
43. Kupersmith MJ, Shakin E, Siegel IM, Lieberman A: Visual system abnormalities in patients with Parkinson's Disease. Arch Neurol 1982,39, 284-286. (Pubitemid 12146424)
44. Holder GE: The pattern electroretinograms. Heckenlively JR et al. Principles and practice of clinical electreophysiology of vision2006, 345.
45. Peppe A, Stanzione P, Pierelli F, De Angelis D, Pierantozzi M, Bernardi G: Visual alterations in de novo Parkinson's disease: pattern electroretinogram latencies are more delayed and more reversible by levodopa than are visual evoked potentials. Neurology 1995 Jun, 45(6), 1144-1148.
46. Calzetti S, Franchi A, Taratufolo G, Groppi E: Simultaneous VEP and PERG investigations in early Parkinson's disease. J Neurol Neurosurg Psychiatry 1990 Feb, 53(2), 114-117. (Pubitemid 20067657)
47. Tagliati M, Bodis-Wollner I, Yahr MD: The pattern electroretinogram in Parkinson's disease reveals lack of retinal spatial tuning. Electroencephalogr Clin Neurophysiol 1996 Jan, 100(1), 1-11.
48. Bodis-Wollner I: Visual electrophysiology in Parkinson's disease: PERG, VEP and visual P300. Clin Electroencephalogr 1997 Jul, 28(3), 143-147.
49. th ISCEV symposium, Padwa 2009, abstract: 72.
50. Knapp AG, Dowling JE: Dopamine enhances excitatory amino acid-gated conductances in cultured retinal horizontal cells. Nature 1987 Jan 29-Feb 4, 325(6103), 437-439. (Pubitemid 17056409)
51. Palmowski-Wolfe AM, Perez MT, Behnke S, Fuss G, Martziniak M, Ruprecht KW: Influence of dopamine deficiency in early Parkinson's disease on the slow stimulation multifocal-ERG. Doc Ophthalmol 2006 May, 112(3), 209-215. (Pubitemid 44295795)
52. Bodis-Wollner I, Yahr MD, Mylin L, Thornton J: Dopaminergic deficiency and delayed visual evoked potentials in humans. Ann Neurol 1982 May, 11(5), 478-483. (Pubitemid 12158808)